1-11042936-G-C

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_006610.4(MASP2):​c.828C>G​(p.Ile276Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000876 in 1,613,864 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00061 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00090 ( 0 hom. )

Consequence

MASP2
NM_006610.4 missense

Scores

5
13

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 0.800

Publications

2 publications found
Variant links:
Genes affected
MASP2 (HGNC:6902): (MBL associated serine protease 2) This gene encodes a member of the peptidase S1 family of serine proteases. The encoded preproprotein is proteolytically processed to generate A and B chains that heterodimerize to form the mature protease. This protease cleaves complement components C2 and C4 in order to generate C3 convertase in the lectin pathway of the complement system. The encoded protease also plays a role in the coagulation cascade through cleavage of prothrombin to form thrombin. Myocardial infarction and acute stroke patients exhibit reduced serum concentrations of the encoded protein. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Feb 2016]
MASP2 Gene-Disease associations (from GenCC):
  • immunodeficiency due to MASP-2 deficiency
    Inheritance: AR Classification: STRONG Submitted by: Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.058052808).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006610.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MASP2
NM_006610.4
MANE Select
c.828C>Gp.Ile276Met
missense
Exon 6 of 11NP_006601.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MASP2
ENST00000400897.8
TSL:1 MANE Select
c.828C>Gp.Ile276Met
missense
Exon 6 of 11ENSP00000383690.3
MASP2
ENST00000700092.1
c.828C>Gp.Ile276Met
missense
Exon 6 of 11ENSP00000514791.1
MASP2
ENST00000700091.1
c.828C>Gp.Ile276Met
missense
Exon 6 of 9ENSP00000514790.1

Frequencies

GnomAD3 genomes
AF:
0.000611
AC:
93
AN:
152210
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000589
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000942
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00115
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000692
AC:
174
AN:
251298
AF XY:
0.000640
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000203
Gnomad ASJ exome
AF:
0.0000994
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000185
Gnomad NFE exome
AF:
0.00142
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000903
AC:
1320
AN:
1461654
Hom.:
0
Cov.:
32
AF XY:
0.000912
AC XY:
663
AN XY:
727140
show subpopulations
African (AFR)
AF:
0.000179
AC:
6
AN:
33474
American (AMR)
AF:
0.000179
AC:
8
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86254
European-Finnish (FIN)
AF:
0.000337
AC:
18
AN:
53386
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5764
European-Non Finnish (NFE)
AF:
0.00112
AC:
1250
AN:
1111854
Other (OTH)
AF:
0.000613
AC:
37
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
75
150
225
300
375
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000611
AC:
93
AN:
152210
Hom.:
0
Cov.:
32
AF XY:
0.000592
AC XY:
44
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.000121
AC:
5
AN:
41440
American (AMR)
AF:
0.000589
AC:
9
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5200
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.0000942
AC:
1
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00115
AC:
78
AN:
68044
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.517
Heterozygous variant carriers
0
5
10
15
20
25
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000730
Hom.:
1
Bravo
AF:
0.000612
TwinsUK
AF:
0.00189
AC:
7
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00140
AC:
12
ExAC
AF:
0.000898
AC:
109
EpiCase
AF:
0.000763
EpiControl
AF:
0.00101

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Immunodeficiency due to MASP-2 deficiency Uncertain:2
Jun 23, 2016
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.47
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.14
T
Eigen
Benign
-0.25
Eigen_PC
Benign
-0.36
FATHMM_MKL
Benign
0.12
N
LIST_S2
Benign
0.66
T
M_CAP
Benign
0.029
D
MetaRNN
Benign
0.058
T
MetaSVM
Benign
-0.89
T
MutationAssessor
Uncertain
2.2
M
PhyloP100
0.80
PrimateAI
Benign
0.35
T
PROVEAN
Uncertain
-2.6
D
REVEL
Benign
0.13
Sift
Uncertain
0.0010
D
Sift4G
Uncertain
0.0040
D
Polyphen
0.26
B
Vest4
0.46
MVP
0.14
MPC
0.24
ClinPred
0.16
T
GERP RS
2.4
Varity_R
0.35
gMVP
0.73
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149800848; hg19: chr1-11102993; COSMIC: COSV107508311; COSMIC: COSV107508311; API